Effect of mirtazapine versus selective serotonin reuptake inhibitors on benzodiazepine use in patients with major depressive disorder: a pragmatic, multicenter, open-label, randomized, active-controlled, 24-week trial

BACKGROUND: This study aimed to evaluate whether selecting mirtazapine as the first choice for current depressive episode instead of selective serotonin reuptake inhibitors (SSRIs) reduces benzodiazepine use in patients with major depressive disorder (MDD). We concurrently examined the relationship...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashimoto, Tasuku, Shiina, Akihiro, Hasegawa, Tadashi, Kimura, Hiroshi, Oda, Yasunori, Niitsu, Tomihisa, Ishikawa, Masatomo, Tachibana, Masumi, Muneoka, Katsumasa, Matsuki, Satoshi, Nakazato, Michiko, Iyo, Masaomi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070072/
https://www.ncbi.nlm.nih.gov/pubmed/27777607
http://dx.doi.org/10.1186/s12991-016-0115-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070072/
https://www.ncbi.nlm.nih.gov/pubmed/27777607
http://dx.doi.org/10.1186/s12991-016-0115-1

Ejemplares similares